Prosecution Insights
Last updated: October 26, 2026

Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

27 pending office actions • 22 art units • 27 examiners • 0 of 27 (0%) have an AI response strategy ready • 39 patents granted in the last 365 days

Analysis

MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V. has 1 pending office action. The matter is assigned to 1 examiner and 1 art unit. No technology area is identified in the available profile data.

CHOI, WOO H is the busiest examiner, with 1 pending matter. The recorded workload is therefore concentrated in that examiner and art-unit assignment, allowing counsel to focus on one prosecution path.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

27
Total Pending OAs
18
Non-Final OAs
9
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

18
Hard (67%)
8
Medium (30%)
1
Easy (4%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (11%)
§103 only5 (19%)
§102 only2 (7%)
§112 only1 (4%)
Double-patenting + other1 (4%)
Multi-statute (no §101)15 (56%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

17
Life Sciences
63% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
3
Semiconductors
11% of docket
5
Mechanical / Eng
19% of docket
2
Business / Other
7% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

270 h
Manual time on pending OAs
54 h
Time saved (low, 20%)
94 h
Time saved (mid, 35%)
2.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GROSS, JASON PATRICK 1 64.0% +43.3%
MONAHAN, MEGAN ELIZABETH 1 59.9% +11.5%
SAIDHA, TEKCHAND 1 82.9% +14.0%
TIWARI, VYOMA SHUBHAM 1 32.1% +47.4%
BOWMAN, ANDREW J 1 65.8% +13.5%
LOUNTOS, GEORGE THEMISTOCLIS 1 57.1% +60.0%
HUYNH, PHUONG N 1 65.8% +53.6%
YOO, SUN JAE 1 71.2% +0.3%
SAMALA, JAGADISHWAR RAO 1 67.9% +55.7%
HYUN, PAUL SANG HWA 1 69.8% +36.3%

Hard Cases (18)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17770259 HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY MIDDLETON, DANAYA L 5d overdue
18729559 TEMPERATURE CONTROL SYSTEM, VACUUM SYSTEM, AND METHOD OF ADJUSTING THE TEMPERATURE OF A VACUUM CHAMBER OF A VACUUM SYSTEM BOWMAN, ANDREW J 4d overdue
17275084 AUTOMATED GENERATION AND ANALYSIS OF ORGANOIDS BATES, KEENAN ALEXANDER 13d
18571926 METHOD OF PREPARING A SURFACE OF A SINGLE CRYSTAL WAFER AS AN EPITAXIAL TEMPLATE, EPITAXIAL TEMPLATE AND DEVICE BRATLAND JR, KENNETH A 76d
19099840 COMPUTER-IMPLEMENTED METHOD AND DEVICE CONFIGURED TO DETERMINE A DESIGN OF A MEDICAL DEVICE COMPRISING A ROD SHAPED PORTION GROSS, JASON PATRICK —
19099843 ENDOSCOPE AND METHOD FOR CONTROLLING THE ENDOSCOPE MONAHAN, MEGAN ELIZABETH —
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION SAIDHA, TEKCHAND —
18728493 GLYCOSIDE HYDROLASE AND/OR TRANSGLYCOSYLASE FOR SYNTHESIS OF XYLOSE OLIGOSACCHARIDES LOUNTOS, GEORGE THEMISTOCLIS —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18729559 TEMPERATURE CONTROL SYSTEM, VACUUM SYSTEM, AND METHOD OF ADJUSTING THE TEMPERATURE OF A VACUUM CHAMBER OF A VACUUM SYSTEM BOWMAN, ANDREW J 4d overdue
19099840 COMPUTER-IMPLEMENTED METHOD AND DEVICE CONFIGURED TO DETERMINE A DESIGN OF A MEDICAL DEVICE COMPRISING A ROD SHAPED PORTION GROSS, JASON PATRICK —
19099843 ENDOSCOPE AND METHOD FOR CONTROLLING THE ENDOSCOPE MONAHAN, MEGAN ELIZABETH —
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION SAIDHA, TEKCHAND —
18839402 HIGH-CONTRAST EN-BLOC STAINING OF MOUSE WHOLE-BRAIN AND HUMAN BRAIN SAMPLES FOR EM-BASED CONNECTOMICS TIWARI, VYOMA SHUBHAM —
18728493 GLYCOSIDE HYDROLASE AND/OR TRANSGLYCOSYLASE FOR SYNTHESIS OF XYLOSE OLIGOSACCHARIDES LOUNTOS, GEORGE THEMISTOCLIS —
18711322 VHH ANTIBODIES AGAINST SARS-COV-2 VARIANTS HUYNH, PHUONG N —
18686456 PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING SAMALA, JAGADISHWAR RAO —

Top Art Units

Art UnitApps
1618 3
1652 2
3797 1
3795 1
1634 1
1717 1
1641 1
1621 1
2855 1
2877 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19099840 COMPUTER-IMPLEMENTED METHOD AND DEVICE CONFIGURED TO DETERMINE A DESIGN OF A MEDICAL DEVICE COMPRISING A ROD SHAPED PORTION GROSS, JASON PATRICK 3797 §101§103§112 Non-Final OA — Pending Jan 30, 2025
19099843 ENDOSCOPE AND METHOD FOR CONTROLLING THE ENDOSCOPE MONAHAN, MEGAN ELIZABETH 3795 §102§103§112Other Non-Final OA — Pending Jan 30, 2025
18856085 METHOD FOR PREPARING ALPHA-BRANCHED BETA'-HYDROXY CARBONYL COMPOUNDS BY ENZYMATIC-CATALYZED REDUCTIVE ALDOL REACTION SAIDHA, TEKCHAND 1652 §102§112 Non-Final OA — Pending Oct 11, 2024
18839402 HIGH-CONTRAST EN-BLOC STAINING OF MOUSE WHOLE-BRAIN AND HUMAN BRAIN SAMPLES FOR EM-BASED CONNECTOMICS TIWARI, VYOMA SHUBHAM 1634 §112 Non-Final OA — Pending Aug 16, 2024
18729559 TEMPERATURE CONTROL SYSTEM, VACUUM SYSTEM, AND METHOD OF ADJUSTING THE TEMPERATURE OF A VACUUM CHAMBER OF A VACUUM SYSTEM BOWMAN, ANDREW J 1717 §102§103§112 Final Rejection 4d overdue Pending Jul 17, 2024
18728493 GLYCOSIDE HYDROLASE AND/OR TRANSGLYCOSYLASE FOR SYNTHESIS OF XYLOSE OLIGOSACCHARIDES LOUNTOS, GEORGE THEMISTOCLIS 1652 §101§112 Non-Final OA — Pending Jul 12, 2024
18711322 VHH ANTIBODIES AGAINST SARS-COV-2 VARIANTS HUYNH, PHUONG N 1641 §102§112 Non-Final OA — Pending May 17, 2024
18704473 PROTEIN AGGREGATION INHIBITING COMPOUNDS FOR PLANT DISEASE CONTROL YOO, SUN JAE 1621 §102 Non-Final OA — Pending Apr 25, 2024
18686456 PURIFIED SIGNAL-ENHANCED CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING SAMALA, JAGADISHWAR RAO 1618 §102§103§112 Non-Final OA — Pending Feb 26, 2024
18580695 SYSTEM FOR DISSOCIATION OF SOLID BIOPSY AND A METHOD FOR INSPECTION HYUN, PAUL SANG HWA — §102§103§112 Non-Final OA — Pending Jan 19, 2024
18574608 Method and apparatus for spatially manipulating at least one particle in a fluid, computer program product and computer-readable storage medium SOTO, JANICE M 2855 §102§103§112Other Non-Final OA — Pending Dec 27, 2023
18574585 Method and apparatus for measuring a force on at least one particle in a fluid, computer program product and computer-readable storage medium PHILLIPS, RUFUS L 2877 §103§112 Non-Final OA — Pending Dec 27, 2023
18573448 CONTINUOUS FLOW PROCESS FOR PRODUCTION OF CATIONIC LIPIDS RHOADES, DEREK JAMES 1692 §103§112 Non-Final OA — Pending Dec 22, 2023
18571926 METHOD OF PREPARING A SURFACE OF A SINGLE CRYSTAL WAFER AS AN EPITAXIAL TEMPLATE, EPITAXIAL TEMPLATE AND DEVICE BRATLAND JR, KENNETH A 1714 §103§112 Final Rejection 76d Pending Dec 19, 2023
18571271 VINYLATED KETO ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING AND SYNTHESIS THEREOF BAEK, JONGHWAN NMN 1618 §103§112 Non-Final OA — Pending Dec 18, 2023
18569496 METHOD OF PRODUCING AN ELECTRODE, ELECTRODE, DRY COATING COMPOSITION, BATTERY AND ELECTRONIC CIRCUIT SUN, MICHAEL Y — §102§103§112 Non-Final OA — Pending Dec 12, 2023
18289283 COMPOSITION COMPRISING AN INHIBITOR OF MITOCHONDRIAL TRANSCRIPTION SAMSELL, RILLA MARIE 1624 §103§112DP Non-Final OA — Pending Nov 02, 2023
18289128 NETWORK OF METAL FIBERS AND METHOD OF ASSEMBLING A FIBER NETWORK HEVEY, JOHN A 1735 §103 Non-Final OA — Pending Nov 01, 2023
18554819 NON-COVALENT HALOTAG LIGANDS CHAO, ALLEN 1622 §103 Final Rejection — Pending Oct 11, 2023
18548910 STORAGE SYSTEM FOR CRYO-EM/ ET SAMPLES MOORE, DEVON TYLEN 3763 §102§103 Final Rejection — Pending Sep 04, 2023
18038622 SENSOR ARRANGEMENT FOR SENSING FORCES AND METHOD FOR FABRICATING A SENSOR ARRANGEMENT PARCO JR, RUBEN C 2853 §102§103§112 Final Rejection — Pending May 24, 2023
18020339 DELIVERY DEVICE HARRIS, WESLEY G 3783 §102 Final Rejection — Pending Feb 08, 2023
17770259 HLA CLASS I SEQUENCE DIVERGENCE AND CANCER THERAPY MIDDLETON, DANAYA L 1674 §101§112 Non-Final OA 5d overdue Pending Apr 19, 2022
17293621 SURFACTANT-STABILIZED FLUID INTERFACE AND DISPERSION COMPRISING ONE OR MORE DROPLETS HAVING A SURFACTANT STABILIZED FLUID INTERFACE KASSA, TIGABU 1619 §103 Final Rejection — Pending May 13, 2021
17275084 AUTOMATED GENERATION AND ANALYSIS OF ORGANOIDS BATES, KEENAN ALEXANDER 1631 §103§112 Non-Final OA 13d Pending Mar 10, 2021
16641059 SLIPPERY MICROPROPELLERS PENETRATE THE VITREOUS HUMOR VU, JAKE MINH 1618 §103 Final Rejection — Pending Feb 21, 2020
16617348 MAGNETICALLY ACTUATED CAPSULE ENDOSCOPE, MAGNETIC FIELD GENERATING AND SENSING APPARATUS AND METHOD OF ACTUATING A MAGNETICALLY ACTUATED CAPSULE ENDOSCOPE TOWA, RENE T 3791 §103 Final Rejection — Pending Nov 26, 2019

Managing Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v. have?

Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v. has 27 pending office actions as of October 2026, spread across 22 art units and 27 examiners.

Which USPTO examiner handles the most Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v. applications?

Jason Patrick Gross has the most, with 1 of Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v.'s pending office actions.

What technology area are Max-planck-gesellschaft Zur Förderung der Wissenschaften E.v.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month